0001517737-24-000004.txt : 20240104 0001517737-24-000004.hdr.sgml : 20240104 20240104114408 ACCESSION NUMBER: 0001517737-24-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUNKEL JOHN F JR CENTRAL INDEX KEY: 0001206990 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19807 FILM NUMBER: 24510630 MAIL ADDRESS: STREET 1: C/O INTUITIVE SURGICAL, INC. STREET 2: 1266 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNOPSYS INC CENTRAL INDEX KEY: 0000883241 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 561546236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 675 ALMANOR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 6505845000 MAIL ADDRESS: STREET 1: 675 ALMANOR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-01-02 0 0000883241 SYNOPSYS INC SNPS 0001206990 RUNKEL JOHN F JR 675 ALMANOR AVENUE SUNNYVALE CA 94085 0 1 0 0 GC & Corporate Secretary 1 Common Stock 2024-01-02 4 M 0 366 354.48 A 27146 D Common Stock 2024-01-02 4 S 0 366 506.18 D 26780 D Common Stock 2024-01-02 4 M 0 570 234.17 A 27350 D Common Stock 2024-01-02 4 S 0 570 506.18 D 26780 D Common Stock 2024-01-02 4 M 0 1572 135.88 A 28352 D Common Stock 2024-01-02 4 S 0 1572 506.18 D 26780 D Non-Qualified Stock Option (right to buy) 135.88 2024-01-02 4 M 0 1572 0.0 D 2020-12-12 2026-12-12 Common Stock 1572 0 D Non-Qualified Stock Option (right to buy) 234.17 2024-01-02 4 M 0 570 0.0 D 2021-12-10 2027-12-10 Common Stock 570 2278 D Non-Qualified Stock Option (right to buy) 354.48 2024-01-02 4 M 0 366 0.0 D 2022-12-09 2028-12-09 Common Stock 366 2929 D Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $505.00 to $507.95. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted August 18, 2023. 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. By: POA Pursuant Liz Ramirez For: John Frederick Runkel, Jr. 2024-01-04